![Shankar Hariharan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shankar Hariharan
Fondateur chez
Scienture, Inc.
Fortune : 433 650 $ au 31/05/2026
Profil
Shankar Hariharan is the founder of Scienture LLC, established in 2024, serving as Chief Executive Officer & Director.
Current jobs include Executive Chairman & Co-Chief Executive Officer at Scienture Holdings, Inc. starting in 2025, Director at DepYmed, Inc., and Advisor at New Rhein Healthcare Investors.
Former jobs include Independent Director at TRxADE HEALTH, Inc. and Chief Scientific Officer and Executive VP at Amneal Intermediate, Inc. from 2010 to 2019.
Education includes a doctorate from Northeastern University and an undergraduate degree from Banaras Hindu University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
6,51% | 30/04/2026 | 1 050 000 ( 6,51% ) | 433 650 $ | 31/05/2026 |
Postes actifs de Shankar Hariharan
| Sociétés | Poste | Début |
|---|---|---|
DepYmed, Inc.
 DepYmed, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of breast cancer | Directeur/Membre du Conseil | - |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Consultant / Advisor | - |
Scienture, Inc.
 Scienture, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company | Fondateur | 25/07/2024 |
Anciens postes connus de Shankar Hariharan
| Sociétés | Poste | Fin |
|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Technique/Scientifique/R&D | 02/04/2019 |
| SCIENTURE HOLDINGS, INC. | Directeur/Membre du Conseil | - |
Formation de Shankar Hariharan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
TRxADE HEALTH, Inc.
 TRxADE HEALTH, Inc. Miscellaneous Commercial ServicesCommercial Services Provides an on-line platform for pharmaceutical purchasers | Commercial Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banaras Hindu University
 Banaras Hindu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
DepYmed, Inc.
DepYmed, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of breast cancer | Health Technology |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Scienture, Inc.
Scienture, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company | Health Technology |
